A detailed history of Coldstream Capital Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,807 shares of CRL stock, worth $357,334. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,807
Previous 1,893 4.54%
Holding current value
$357,334
Previous $391,000 9.21%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$187.96 - $245.29 $16,164 - $21,094
-86 Reduced 4.54%
1,807 $355,000
Q2 2024

Aug 07, 2024

SELL
$206.39 - $268.73 $1,031 - $1,343
-5 Reduced 0.26%
1,893 $391,000
Q1 2024

May 13, 2024

BUY
$203.52 - $273.43 $26,457 - $35,545
130 Added 7.35%
1,898 $514,000
Q4 2023

Feb 09, 2024

BUY
$164.52 - $238.84 $290,871 - $422,269
1,768 New
1,768 $417,000
Q2 2023

Aug 03, 2023

SELL
$183.71 - $210.25 $20,942 - $23,968
-114 Reduced 9.49%
1,087 $228,000
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $68,696 - $93,051
-358 Reduced 22.96%
1,201 $242,000
Q4 2022

Jan 10, 2023

BUY
$197.11 - $250.07 $92,641 - $117,532
470 Added 43.16%
1,559 $0
Q2 2022

Aug 08, 2022

SELL
$204.13 - $302.4 $210,662 - $312,076
-1,032 Closed
0 $0
Q2 2022

Aug 08, 2022

BUY
$204.13 - $302.4 $222,297 - $329,313
1,089 New
1,089 $233,000
Q1 2022

May 11, 2022

SELL
$255.51 - $362.11 $1,277 - $1,810
-5 Reduced 0.48%
1,032 $293,000
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $14,757 - $18,844
-42 Reduced 3.89%
1,037 $391,000
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $17,886 - $21,998
-48 Reduced 4.26%
1,079 $244,000
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $14,414 - $18,210
49 Added 4.55%
1,127 $417,000
Q1 2021

Jun 16, 2021

BUY
$249.67 - $299.48 $3,495 - $4,192
14 Added 1.32%
1,078 $312,000
Q4 2020

Feb 16, 2021

BUY
$222.0 - $252.62 $2,664 - $3,031
12 Added 1.14%
1,064 $266,000
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $184,689 - $238,225
1,052 New
1,052 $238,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.